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Excitotoxic superoxide production 
and neuronal death require both 
ionotropic and non-ionotropic 
NMDA receptor signaling
Angela M. Minnella1,2, Jerry X. Zhao1,2, Xiangning Jiang4, Emil Jakobsen5, Fuxin Lu4, Long Wu  1,2, 
Jamel El-Benna6,7, John A. Gray3 & Raymond A. Swanson  1,2
NMDA-type glutamate receptors (NMDAR) trigger superoxide production by neuronal NADPH 
oxidase-2 (NOX2), which if sustained leads to cell death. This process involves Ca2+ influx through 
NMDAR channels. By contrast, comparable Ca2+ influx by other routes does not induce NOX2 activation 
or cell death. This contrast has been attributed to site-specific effects of Ca2+ flux through NMDAR. 
Here we show instead that it stems from non-ionotropic signaling by NMDAR GluN2B subunits. To 
evaluate non-ionotropic effects, mouse cortical neurons were treated with NMDA together with 
7-chlorokynurenate, L-689,560, or MK-801, which block Ca2+ influx through NMDAR channels but not 
NMDA binding. NMDA-induced superoxide formation was prevented by the channel blockers, restored 
by concurrent Ca2+ influx through ionomycin or voltage-gated calcium channels, and not induced by 
the Ca2+ influx in the absence of NMDAR ligand binding. Neurons expressing either GluN2B subunits 
or chimeric GluN2A/GluN2B C-terminus subunits exhibited NMDA-induced superoxide production, 
whereas neurons expressing chimeric GluN2B/GluN2A C-terminus subunits did not. Neuronal NOX2 
activation requires phosphoinositide 3-kinase (PI3K), and NMDA binding to NMDAR increased PI3K 
association with NMDA GluN2B subunits independent of Ca2+ influx. These findings identify a non-
ionotropic signaling pathway that links NMDAR to NOX2 activation through the C-terminus domain of 
GluN2B.
N-methyl-D-aspartate - type glutamate receptors (NMDAR) are expressed throughout the mammalian central 
nervous system. NMDAR are crucial for synaptic plasticity and learning, but can also mediate neuronal cell 
death. Most NMDAR are comprised of heteromeric assemblies of GluN1 and GluN2 subunits, both of which 
have C-terminal domains that extend into the neuronal cytoplasm. Agonist binding to glutamate sites on GluN2 
subunits, in conjunction with co-agonist binding to glycine sites on GluN1 subunits, opens a receptor channel 
that is permeable to Ca2+ and other cations1. This ionotropic property is required for several downstream effects 
of NMDAR activation2–4. Though less widely recognized, NMDAR also have non-ionotropic signaling effects, i.e. 
signaling effects that are independent of receptor-gated ion flux5–10. These non-ionotropic signaling effects may 
be transmitted through ligand-induced conformational changes in the C-terminal cytoplasmic domains of GluN1 
or GluN2 subunits11.
One of the downstream effects of neuronal NMDAR activation is production of superoxide12. Phsiological 
neuronal superoxide production has intercellular signaling functions13,14, but excessive neuronal superoxide pro-
duction contributes to excitotoxic cell injury15,16. Superoxide produced in response to NMDAR stimulation is 
generated primarily by NADPH oxidase-2 (NOX2), and interventions that prevent NOX2 activation prevent 
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excitotoxic cell death17–22. NMDA-induced NOX2 activation and neuronal death are both prevented by blocking 
Ca2+ influx through NMDAR18,23,24, indicating a requisite role for ionotropic, NMDAR-gated calcium influx. By 
contrast, Ca2+ influx of comparable magnitude through other routes does not trigger these events24,25. This con-
trast may be reconciled by the possibility that Ca2+ influx specifically through NMDAR has privileged access to 
local signaling pathways25,26. However, an alternative possibility is that NOX2 activation requires, in addition to 
Ca2+ influx, a non-ionotropic signaling effect induced by ligand binding to NMDAR.
Here we evaluated this alternative possibility using primary mouse cortical neuron cultures. Results of these 
studies show that NMDA - induced NOX2 activation and cell death requires, in addition to calcium influx, 
non-ionotropic signaling mediated by the C-terminal cytoplasmic domain of GluN2B subunits.
Results
Using mouse cortical neuron cultures, we confirmed that NMDA - induced superoxide production was pre-
vented by a peptide inhibitor of NADPH oxidase-2 (NOX2) (Fig. 1). This result is consistent with prior studies 
showing that NOX2 is the primary source of superoxide production during NMDAR activation (as reviewed 
in16). Superoxide production was also prevented by omitting Ca2+ from the medium, confirming that neuronal 
NOX2 activation requires Ca2+ influx. In contrast to NMDA, the Ca2+ ionophore ionomycin did not significantly 
increase superoxide production (Fig. 1) despite producing intracellular Ca2+ changes that were comparable in 
magnitude and kinetics to those produced by NMDA (Fig. 2, Suppl. Fig. S1).
Given that NMDAR activation and ionomycin produced calcium elevations of similar rate and magnitude, but 
only NMDAR activation led to superoxide production, we asked whether superoxide production might require 
non-ionotropic signaling by NMDAR in addition to Ca2+ influx. To do this, we dissociated the non-ionotropic 
and ionotropic effects of NMDAR activation using a previously established pharmacological approach in which 
neurons are treated with the NMDAR glycine site antagonist 7-chlorokynurenate (7CK) to inhibit NMDAR chan-
nel opening without blocking NMDA binding6–9,27. Studies performed in this way confirmed that 7CK blocked 
NMDA-induced superoxide production (Fig. 3), as would be expected given its block of Ca2+ influx. When neu-
rons treated with NMDA + 7CK were additionally treated with ionomycin to provide a Ca2+ influx, superoxide 
production was restored. Crucially, this result contrasts with the lack of superoxide production in neurons treated 
with ionomycin in the absence of NMDA. These results suggest that the signaling pathway linking NMDAR to 
superoxide production requires a non-ionotropic effect of ligand binding to NMDAR, in addition to Ca2+ influx.
The rate and magnitude of intracellular Ca2+ elevations induced by these treatments were assessed using 
the high-affinity calcium indicator Fura-2 (Fig. 2a–g). The rates of calcium elevations induced by NMDA and 
ionomycin were not significantly different, with half-maximal effects achieved within 4 minutes (Suppl. Fig. 1a) 
and near-maximal effects within 8 minutes (Fig. 2) in all conditions. The Fura-2 observations also confirmed 
that both 7CK and the competitive NMDAR inhibitor (2R)-amino-5-phosphonovaleric acid (AP5) effectively 
blocked Ca2+ elevations at the concentrations employed, and that the magnitude of Ca2+ elevation induced by the 
ionomycin + 7CK + NMDA condition did not exceed that induced by NMDA alone. We additionally evaluated 
the magnitude of Ca2+ elevation using the low affinity dye Fura-FF, to exclude the possibility that differences in 
maximal Ca2+ elevations over the duration of these studies might be masked by saturation of the high-affinity 
Fura-2 indicator. The results obtained with Fura-FF were in agreement with those obtained with Fura-2 (Fig. 2h).
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Figure 1. NMDA-induced superoxide production is Ca2+ -dependent, but not induced by Ca2+ influx alone. 
(a) Images show superoxide production, as measured by ethidium fluorescence (red), after incubation with 
NMDA (100 µM, 25 min). Scale bar = 20 µm. The NMDA-induced superoxide production is prevented by a 
Tat-conjugated peptide inhibitor of NOX2 (gp91ds-Tat, 3 µM) but not by a Tat-conjugated control peptide 
(scr-Tat). Superoxide production is also prevented by omitting Ca2+ from the medium. Superoxide production 
is not induced by ionomycin (3 µM). (b) Quantification of results shown in a, with results from each of n = 3 
experiments expressed as percent of the NMDA-treated condition. Data are means + s.e.m.; *p < 0.01 vs 
control.
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7CK has been used in several prior studies to uncover non-ionotropic effects of NMDAR activation6–9,27, but 
nevertheless there is a possibility that off-target effects might affect the observations. Accordingly, the studies 
performed here with 7CK were also performed with a structurally distinct glycine site antagonist, L-689,56028 
and with the open-channel blocker, MK-801. Like 7CK, L-689,560 and MK-801 prevented NMDA-dependent 
increases in superoxide production, and co-incubation with ionomycin reversed this effect (Fig. 3). The results 
obtained with 7CK, L-689,560, and MK-801 contrast with those obtained with the competitive NMDAR antag-
onist, AP5. AP5 blocks NMDA binding to GluN2 subunits of NMDAR and thus prevents non-ionotropic 
NMDA signaling, in addition to blocking NMDAR -mediated calcium influx. As expected, AP5 prevented 
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Figure 2. Ionomycin can mimic the intracellular Ca2+ elevation induced by NMDA. (a–f) Traces show mean 
changes in intracellular Ca2+ (black line) measured in individual neurons (gray lines) loaded with the high-
affinity Ca2+ indicator Fura-2. Arrows mark addition of 100 µM NMDA or 3 µM ionomycin. The Ca2+ rise 
induced by NMDA is blocked by either 100 µM 7CK or 30 µM AP5 (c,d), and in the presence of these inhibitors 
the additional presence of 3 µM ionomycin reconstitutes the Ca2+ increase (e,f). (g,h) Panels show aggregate 
intracellular peak Ca2+ elevations as measured by the high affinity dye Fura-2 and low affinity dye Fura-FF, 
respectively. Note the mean Ca2+ elevation induced by 3 µM ionomycin does not exceed that induced by 
NMDA. Values are expressed relative to the mean values of the control condition in each of n = 4 experiments. 
Data are means + s.e.m.; *p < 0.05 vs control.
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NMDA-induced superoxide production and this effect was not reversed by co-incubation with ionomycin 
(Fig. 3).
We also considered the possibility that ionomycin might have off-target effects that could influence the obser-
vations. We therefore also used a second way to induce Ca2+ influx, activation of voltage-gated calcium chan-
nels. This was accomplished as previously described26,29, using elevated KCl (50 mM) to cause depolarization, 
1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)pyridine-3-carboxylic acid methyl ester (Bay 
K8644, 500 nM) to prevent channel inactivation, and an elevated medium Ca2+ content (5 mM). These condi-
tions produced a calcium influx of similar rate and magnitude to that achieved with NMDA (Fig. 4, Suppl. Fig. 
1b). As shown in Fig. 5, results of studies using this method to induce Ca2+ elevations gave results parallel to 
those observed with ionomycin. The intracellular Ca2+ rise induced by KCl + Bay K8644 + 5 mM calcium did 
not itself induce superoxide production, nor did ligand binding to NMDAR in the absence of calcium influx 
(NMDA + 7CK). However, the calcium influx induced by KCl + Bay K8644 + 5 mM calcium when combined 
with ligand binding (NMDA + 7CK) induced a robust superoxide production (Fig. 5a,b). This superoxide pro-
duction was attributable to NOX2 activation, as it was completely negated by the NOX2 inhibitory peptide 
gp91ds-Tat (Fig. 5c).
We confirmed the effects of non-ionotropic NMDAR signaling on superoxide production with two additional 
markers of oxidative stress, DNA damage and lipid peroxidation, and by assessing cell death. DNA strand breaks 
(as identified by foci of γH2AX accumulation) and lipid peroxidation were observed in neurons treated with 
NMDA alone or with NMDA + 7CK + ionomycin, but not in neurons treated with NMDA + AP5 + ionomycin 
(Fig. 6a–c), indicating a requirement for agonist binding to NMDAR in addition to Ca2+ influx. Assessment of 
neuronal death at 24 hours after NMDA exposure revealed the same pattern, using either ionomycin or KCl + Bay 
K8644 + 5 mM CaCl2 to provide calcium influx during NMDAR ligand binding (Fig. 6d,e).
The assembly of an activated NOX2 complex requires phosphorylation of the NOX2 p47phox subunit at ser-
ine 32824,30. Immunostaining for phospho-Ser328-p47phox confirmed that NMDAR activation induced phos-
phorylation of this residue (Fig. 7). Importantly, these studies also showed that the p47phox phosphorylation 
required a non-ionotropic effect of NMDAR stimulation: p47phox became phosphorylated in cultures treated with 
NMDA + 7CK + ionomycin (which prevents ion flux through the NMDAR but not ligand binding), but not in 
cultures treated with NMDA + AP5 + ionomycin (which prevents NMDA binding).
Evidence suggests that NMDAR that contain GluN2B subunits are preferentially involved in superoxide pro-
duction and excitotoxic cell death24,31,32. Here we prepared neurons deficient in GluN2B, GluN2A, or both subunit 
types using Cre-induced excision of their corresponding floxed loci33. NMDA-induced superoxide production 
was robust and comparable in Wt and GluN2A deficient neurons, but negligible in GluN2B deficient neurons 
(Fig. 8a), suggesting signaling through GluN2B but not GluN2A. However, an alternative explanation for this 
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Figure 3. NMDA-induced superoxide production requires both Ca2+ influx and ligand binding. Images 
show superoxide production as measured by ethidium fluorescence (red). (a) NMDA-induced superoxide 
production, is prevented by 7CK (100 µM), L-689, 560 (1 µM), or MK801 (10 µM), which block NMDAR 
channel flux but not NMDA binding; and by 30 µM AP5, which blocks NMDA binding. The addition of 
ionomycin (3 µM) restores superoxide production in cultures treated with NMDA plus the channel inhibitors, 
but not in cultures treated with NMDA + AP5. (b,c) Quantification of results shown in (a) with results from 
each of n = 3 experiments expressed relative to the NMDA condition. Data are means + s.e.m.; *p < 0.05 vs 
control.
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result is low-level GluN2A expression in the cultures, as GluN2A expression is low embryonically and increases 
with age34. Accordingly, we also evaluated neurons that were rendered deficient in native GluN2A and GluN2B 
and transfected to selectively express either GluN2A or GluN2B only. This approach was also used to selectively 
express chimeric GluN2A containing C-terminal GluN2B, or chimeric GluN2B containing C-terminal GluN2A. 
In neurons lacking both GluN2A and GluN2B, cells transfected with GluN2B but not GluN2A exhibited super-
oxide production in response to NMDA (Fig. 8b), thus supporting a specific role for GluN2B in this process. 
Importantly, GluN2A/GluN2B deficient neurons that were transfected with a chimeric GluN2A construct con-
taining the GluN2B C-terminus (GluN2A-ct2B) also exhibited superoxide production, while those transfected 
with chimeric GluN2B subunits containing the GluN2A C-terminus (GluN2B-ct2A) did not (Fig. 8b). Prior stud-
ies have demonstrated efficient transfection-mediated expression of each of these constructs in immature neuron 
cultures35–38, and electrophysiological characterization of these constructs expressed in brain slices confirmed that 
their intrinsic conductances are very similar (Suppl. Fig. S2). Together, these observations support the importance 
of the GluN2B C-terminus in NMDAR-induced NOX2 activation, and argue against the possibility that the ina-
bility of GluN2A subunits to induce NOX2 activation is because of reduced GluN2A expression or current flux.
The signaling pathway linking NMDAR activation to NOX2 activation requires PI3K activation, which 
in turn induces the phosphorylation of p47phox by the atypical (PI3K-activated) protein kinase C, PKCzeta24. 
NMDA-induced PI3K activation involves binding of the p85 regulatory subunit of PI3K to GluN2B, either directly 
or via an adaptor protein39–41. To determine whether this binding is induced by non-ionotropic NMDAR signa-
ling, we immunoprecipitated GluN2B and evaluated for co-precipitation of p85. Results of these studies showed 
an NMDA-induced association of p85 with GluN2B even in the presence of 7CK, indicating a non-ionotropic 
mechanism. As expected, this association was blocked by AP5 and not induced by ionomycin (Fig. 8c,d).
The factors determining p85 binding to GluN2B are poorly understood. However, several lines of evidence 
indicate that phosphorylation at GluN2B Tyr1472 is required for NMDA-induced NOX2 activation42,43, and that 
phosphorylation at GluN2B Tyr1336 promotes p85 binding40. Phosphorylation at these sites is mediated by Src 
kinases, predominately Src and Fyn, which when activated are themselves phosphorylated at Tyr416. We eval-
uated phosphorylation at each these sites by preparing immunoblots from cultures treated for 5 minutes with 
NMDA or NMDA + 7CK. These blots did not, however, reveal any significant NMDA-induced changes in the 
phosphorylation status of these sites (Suppl. Fig. S3). The 5 -minute incubation period was used to avoid GluN2B 
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Figure 4. Activation of voltage-gated calcium channels can mimic the intracellular Ca2+ elevations induced 
by NMDA. (a–d) Traces show mean changes in intracellular Ca2+ (black line) measured in individual neurons 
(gray lines) loaded with the high-affinity Ca2+ indicator Fura-2. For clarity only every other obtained trace is 
shown. Arrows mark addition of either 100 µM NMDA or 50 mM KCl + 500 nM Bay K8644. Where indicated, 
the Ca2+ concentration in the medium was increased to 5 mM. The intracellular Ca2+ rise induced by NMDA 
is blocked by 100 µM 7CK (c), and in the presence of 7CK the addition of KCl + Bay K8644 reconstitutes the 
Ca2+ increase (d). (e) Panel shows the aggregate intracellular peak Ca2+ elevations as measured by Fura-2. Note 
the mean Ca2+ elevation induced by 50 mM KCl + Bay K8644 in 5 mM Ca2+ medium does not exceed that 
induced by NMDA. Values from each of n = 4 independent experiments are expressed relative to the control (no 
NMDA) condition. Data are means + s.e.m.; *p < 0.05 vs control.
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cleavage during NMDA incubation44. An additional set of studies using 30-minute incubation intervals also 
revealed no significant phosphorylation changes.
Discussion
Ca2+ elevations mediated by NMDAR activation lead to excitotoxic neuronal death, whereas comparable Ca2+ 
elevations mediated by other Ca2+ entry routes do not25,26. The reason for this difference has not been established, 
but it is widely thought to stem from a privileged access to local signaling pathways by Ca2+ influx through 
NMDAR. The present findings suggest instead that this difference is attributable to non-ionotropic signaling 
induced by agonist binding to GluN2B - containing NMDAR. They demonstrate that Ca2+ influx produced by 
either ionomycin or voltage-gated calcium channels fails to induce superoxide formation or neuronal death unless 
there is a concomitant binding of ligand to NMDAR. These findings further indicate that the GluN2B C-terminal 
domain mediates this non-ionotropic effect of NMDAR activation. Prior studies have shown that PI3K activation 
is required for neuronal NOX2 activation24, and the present results also show that agonist binding to NMDAR 
(in the absence of Ca2+ influx) is sufficient to induce association of the PI3K p85 regulatory subunit to GluN2B.
Our findings add to previously identified roles for non-ionotropic NMDAR signaling45. This signaling mech-
anism was first described by Westbrook and colleagues, who found that agonist binding independent of ion flux 
could downregulate current flux through NMDAR through a process involving de-phosphorylation of GluN1 
tyrosine residues5. Non-ionotropic effects of NMDAR were subsequently shown to mediate long-term depression, 
p38 phosphorylation6,7, and dendritic spine shrinkage9. A synergistic interaction between NMDAR and mGlu5 
receptors on gene expression was likewise found to require NMDAR agonist binding but not current flux46. In 
addition to glutamate binding, glycine binding to NMDA receptors on its GluN2A subunit has been shown to 
have a non-ionotropic effect that promotes cell survival when ionic flux is blocked47. None of these reports iden-
tify the molecular mechanism by which ligand binding mediates these effects, but a study using fluorescence 
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resonance energy transfer (FRET) demonstrated that agonist binding to NMDAR, without ion flow, can drive 
rapid and reversible movement of C-terminus cytoplasmic domains11,48, suggesting that conformational changes 
in these domains enable subsequent downstream signaling.
Superoxide has a variety of intercellular signaling roles both in brain and other tissues13,14,49,50. However, super-
oxide and its downstream reactive oxygen metabolites (including hydrogen peroxide, hydroxyl radical, peroxyni-
trite and others) can also contribute to pathogenesis of stroke and neurodegenerative disorders15,16,51,52. Superoxide 
can be produced by several mechanisms, but in the present studies the complete suppression of the superoxide 
ethidium signal with a peptide inhibitor of NOX2 established NOX2 as the primary source of NMDA-induced 
superoxide production. This is consistent with several prior reports in which suppression of NOX2 activity by 
pharmacological or genetic approaches blocked the superoxide formation, lipid oxidation, DNA damage, and cell 
death resulting from NMDAR activation16,18,20,53. Elevations in intracellular Ca2+ to levels substantially above those 
induced by 100 µM NMDA can, however, induce neuronal superoxide production from a source that is insensitive 
to NOX2 inhibitors, presumably mitochondria24,29. The ionomycin and voltage-gated calcium activation conditions 
used in the present studies were therefore titrated to ensure that neither the rates nor magnitude of Ca2+ elevation 
exceeded those induced by NMDA. Our measures of intracellular Ca2+ elevations were made in neuronal soma, 
which could underestimate (or overestimate) elevations that occur in subdomains such as dendritic processes or 
synaptic boutons. That, however, would not affect the conclusion that the Ca2+ elevations alone do not induce 
superoxide production or cell death in the absence of ligand binding to NMDAR.
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Figure 6. NMDA-induced DNA damage, lipid peroxidation, and cell death require both Ca2+ influx 
and ligand binding. (a) Double stranded DNA breaks are visualized by foci of γH2Ax immunoreactivity 
(red) after incubation with either NMDA or NMDA + 7CK + ionomycin, but not after incubation 
with NMDA + AP5 + ionomycin. Scale bar = 5 µm. (b) Quantification of results shown in a. (c) 
Increased lipid peroxidation after incubation with NMDA or NMDA + 7CK + ionomycin, but not after 
incubation with NMDA + AP5 + ionomycin. (d) Increased cell death after incubation with NMDA or 
NMDA + 7CK + ionomycin, but not after incubation with NMDA + AP5 + ionomycin or with ionomycin 
in the absence of NMDA. (e) Increased cell death after incubation with NMDA or NMDA + 7CK + voltage-
gated calcium channel activation (Bay K8644 in 50 mM KCl and 5 mM CaCl2), but not after activation of 
voltage-gated calcium channels in the absence of NMDA. Treatment conditions are as in Figs 3 and 5. Data are 
means + s.e.m., expressed as fold increase over control. Cell death in the control groups was 21 ± 8%. n = 3–5; 
*p < 0.05 vs control.
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The use of primary neuron cultures in these studies facilitated genetic and pharmacological manipulations and 
the measurements of Ca2+ elevations and superoxide production; however, cultured neurons do not fully reflect 
behavior of neurons in vivo. In particular, they exhibit reduced expression of the GluN2A NMDAR subunit dur-
ing the first two weeks in vitro34. This limitation can be circumvented by transfecting the neurons with native or 
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Figure 7. Phosphorylation of NADPH oxidase p47phox requires both Ca2+ influx and ligand binding. Scale 
bar = 5 µm. (a) Increased phosphorylation of p47phox at Ser328 occurs after incubation with NMDA or 
NMDA + 7CK + ionomycin, but not after incubation with NMDA + AP5 + ionomycin or with ionomycin in 
the absence of NMDA. Conditions are as in Fig. 3. (b) Quantification of results shown in (a), with data in each 
of n = 3 experiments normalized to the control condition; *p < 0.05 vs control.
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chimeric GluN2 constructs35–38, as performed in the present study. Here, NMDA induced superoxide production 
in neurons that selectively expressed GluN2B (but not GluN2A) and in neurons that selectively expressed chimeric 
GluN2A containing C-terminal GluN2B (but not GluN2B containing C-terminal GluN2A), indicating that the 
GluN2B C-terminal domain is required. This is an important aspect of our results, because GluN2B - containing 
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Figure 8. NMDA-induced superoxide production is mediated through the C-terminal cytoplasmic domain 
of GluN2B and is associated with PI3K binding. (a) Selective deletion of GluN2B but not GluN2A subunits 
prevents superoxide formation induced by NMDA. Cultures were treated with NMDA as in Fig. 3, with results 
from each of n = 3 experiments expressed relative to the NMDA treated condition; *p < 0.05 vs control. (b) In 
neurons lacking both endogenous GluN2A and GluN2B, NMDA-induced superoxide production was observed 
in cultures transfected with either the GluN2B subunit (GluN2B wt) or the GluN2A subunit fused to a GluN2B 
C-terminal domain (GluN2A-ct2B), but not in cultures transfected with GluN2A wt or GluN2B-ct2A. Results 
from each of 3 experiments are expressed relative to signal obtained in cultures transfected with the empty 
vector GFP (Ev-GFP). The reduced magnitude of the NMDA effect in the GluN2B - transfected neurons (b) 
relative to that observed in Wt neurons (a) is consistent with the transfection efficiency of approximately 10% 
achieved with each of the GluN2 constructs. Data are means + s.e.m.; *p < 0.05 v Ev-GFP. (c) Immunoblots 
(IB) of PI3K p85 and GluN2B in lysates immunoprecipitated (IP) with antibody to GluN2B. IP with normal 
mouse IgG served as negative control. The p85 band is at ~90 kD and the GluN2B band at ~200 kD. An aliquot 
of the cell lysate was used as an input control to verify the presence of detected protein in the original samples. 
Full-length blots are presented in Supplementary Fig. S4. (d) Quantified results of p85 binding to GluN2B 
normalized to the control values; n = 3; *p < 0.05 vs control.
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NMDAR have previously been shown to have a dominant role in both neuronal NOX2 - mediated superoxide 
production and excitotoxic cell death24,36,54.
A second limitation to this study is that it does not identify the non-ionotropic signal transduction mechanism 
at the molecular level. Our results do point to a potential mechanism by showing that agonist binding to NMDAR 
increases the association between GluN2B and the p85 regulatory subunit of PI3K. This is significant because 
PI3K activity is required to activate protein kinase C zeta, which in turn phosphorylates and activates the NOX2 
p47phox subunit24. As prior studies using FRET have shown agonist – induced conformational changes in NMDAR 
C-terminus domain11,48, this observation suggests that p85 binding to GluN2B may be enabled by a conformation 
change triggered by NMDA binding to GluN2B. Although our studies did not identify changes in GluN2B phos-
phorylation state associated with p85 binding, they do not exclude phosphorylation that may occur selectively 
in the synaptic, membrane-bound pool of NMDAR or at extrasynaptic sites, or other types of post-translational 
modifications. It is also possible that a conformational change alone is sufficient to permit p85 binding, without 
associated changes in phosphorylation, acetylation, or other modifications.
Non-ionotropic signaling provides an additional layer of complexity to NMDAR physiology. A study pub-
lished during preparation of this manuscript describes a neuroprotective effect of non-ionotropic NMDAR in 
brain ischemia, through a mechanism involving AMPA receptor function55. Another recent study identifies a role 
for non-ionotropic NMDA signaling in the cytotoxic opening of pannexin channels under excitotoxic conditions, 
and places irreversible neuronal injury downstream of pannexin channel opening10. It will be thus be important 
to determine whether the signaling pathway identified here in neuronal cultures is likewise functioning in intact 
brain, and whether it contributes to pannexin channel opening under excitotoxic conditions.
The capacity for both ionotropic and non-ionotropic NMDAR signaling may allow NMDA receptor com-
plexes to initiate different signaling events depending upon subunit composition, agonist and co-agonist availa-
bility, and intracellular Ca2+ levels. Given that intracellular Ca2+ dynamics are influenced by the aggregate effect 
of local NMDAR activation, this property may also provide a mechanism whereby the non-ionotropic effect of 
agonist binding to single NMDAR can be influenced by concomitant ionotropic activity of neighboring NMDAR.
Materials and Methods
Studies were performed in accordance with protocols approved by the University of California, San Francisco and 
San Francisco Veterans Affairs Medical Center animal studies subcommittees. Cell culture reagents were obtained 
from Mediatech, and all other reagents were obtained from Sigma-Aldrich except where noted. Data analyses for 
all studies were performed by observers blinded to the experimental conditions.
Cortical cultures. Mixed neuron-astrocyte cultures were prepared from the cortices of embryonic day 16–18 
mice and plated in 24-well culture plates or poly-D-lysine coated glass coverslips18. After 4 days in culture, 1.2 µM 
cytosine arabinoside was added to culture media to suppress astrocyte proliferation. The cells were subsequently 
maintained in NeuroBasal medium (Gibco) containing 5% FBS, 5 mM glucose, and used at day 10–15 in vitro.
Experimental conditions. The culture medium was replaced with a low-magnesium balanced salt solution 
(BSS): 137 mM NaCl2, 1.2 mM CaCl2, 0.4 mM MgSO4, 5.3 mM KCl, 0.4 mM NaH2PO4, 0.3 mM Na2HPO4, 5 mM 
glucose, and 10 mM 1,4-piperazinediethanesulfonate (PIPES) buffer, pH 7.3. Where a “high calcium” medium 
was used, the CaCl2 concentration was increased to 5 mM and NaCl concentration was reduced to 133 mM. 
Experiments were initiated by the addition of either N-methyl D-aspartate (NMDA), ionomycin, or KCl plus Bay 
K8644 from concentrated stocks. Where used, the NMDA receptor blockers 7CK, AP5, MK-801, and L-689,560 
were added 10 minutes prior to NMDA.
Intracellular calcium imaging. Neurons were loaded for 30 minutes with either 4 µM Fura-2 AM or 
Fura-FF AM (Molecular Probes) and washed once with BSS prior to imaging. Images were acquired at 20 second 
intervals, using excitation that alternated between 340 nm and 380 nm (emission > 510 nm). Raw fluorescence 
was normalized to baseline levels prior to stimulus. Calcium elevations were then expressed as change in the 
ratio of 340 nm/380 nm fluorescence. Fura-FF measures were all well below saturation24. Maximal values and 
time to half-maximal values were calculated over the interval of 0–25 minutes after addition of test compounds 
to the media, using the normalized data obtained from more than 10 neurons from each of n = 3 independent 
experiments.
Superoxide imaging. Five µM dihydroethidium (Invitrogen) was added to cultures 10 minutes prior to 
the addition of the test compounds (NMDA, ionomycin, or Bay K8644) and maintained throughout the exper-
iment. The cultures were photographed after 25 minutes incubation with a fluorescence microscope (Axiovert 
40 CFL, Zeiss) using 510–550 nm excitation and >580 nm emission, and with transmitted light phase contrast. 
The fluorescence of oxidized ethidium species (Eth) was measured in 3 randomly chosen optical fields from each 
culture well and calculated as mean Eth fluorescence [area (pixels) X intensity (arbitrary units)] normalized to the 
cell number counted in the phase contrast images of each optical field. Measurements were made in 4 wells per 
experiment, with >100 neurons per well for a total of >500 neurons per “n”. Superoxide (or a superoxide metab-
olite) was confirmed as the reactive oxidant by negation of Eth formation in the studies where NOX2 activity was 
blocked.
Live cell lipid peroxidation. Image-iT lipid peroxidation kit was purchased from Molecular Probes, and 
labeling and detection methods were followed as described in the protocol. Briefly, cells were treated with drugs 
as described above, and the lipid peroxidation sensor (10 µM) was added to each well. After 20 minutes, the cells 
were washed twice with control BSS and images were prepared from 3 randomly selected regions in each well 
to evaluate fluorescence at 590 nm to 510 nm. The ratio of signal intensities was calculated as a measure of lipid 
www.nature.com/scientificreports/
1 1SCieNtiFiC REpoRtS |         (2018) 8:17522  | DOI:10.1038/s41598-018-35725-5
peroxidation. Measurements were made in 4 wells per experiment, with >100 neurons per well, for a total of 
400–500 neurons per “n”.
GluN2 subunit deletion and C-terminal domain swaps. Primary neuron cultures were prepared 
as described using Grin2afl/fl (GluN2A) or Grin2bfl/fl (GluN2B) mice33,56. On culture day 2, the cultures were 
infected with rAAV1-Cre:BFP viral stock (~1 × 1012 vg/ml), expressing a nuclear targeted Cre:BFP fusion protein. 
Experiments were initiated after 11 days in culture. For C-terminal domain swap studies, cultures were prepared 
from double-floxed Grin2afl/flGrin2bfl/fl (GluN2A/GluN2B) mice. Cultures were infected on day 2 in culture with 
rAAV1-Cre:BFP to eliminate expression of the floxed genes, and lipofectamine transfected on culture day 6 with 
either pCAGGS-GFP or pCAGGS-GluN2X-IRES-GFP (where X is wild-type or chimeric GluN2A or GluN2B). 
The C-terminal domains were swapped at E838 of GluN2A and E839 of GluN2B. Transfection efficiency was 
assessed as the fraction of GFP-positive cells in each well, and showed no significant differences among the con-
structs used.
Immunostaining. Formaldehyde-fixed cultures were immunostained as described previously18 using mouse 
antibody to microtubule-associated protein 2 (MAP2, Chemicon, 1:500) or rabbit antibody to anti-Ser129-Histone 
H2AX (1:500, Cell Signaling Technology). Antibodies to phospho-p47phox (Ser 328) were generated and char-
acterized previously57. Antibody binding was visualized with Alexa Fluor 488-conjugated anti-mouse IgG or 
Texas Red 594-conjugated anti-rabbit IgG (Invitrogen). Images were obtained using confocal fluorescence 
microscopy using step-wise 1 µm z-stack sampling. In some cases cell nuclei were also identified for fluores-
cence imaging by incubation with 1 µM 4′, 6-diamidino-2-phenylindole (DAPI) after antibody removal. Neurons 
were analyzed in 3 randomly chosen optical fields from each of 4 coverslips per experiment, with >100 neurons 
per coverslip, for a total of 400–500 neurons per “n”. Staining was quantified as fluorescence [area (pixels) × 
intensity (arbitrary units)]/neuronal surface area (pixels with MAP2 immunoreactivity).
Immunoblots. Cultures were treated under the designated conditions for either 5 or 30 minutes at 37 °C, 
then harvested in RIPA lysis buffer containing protease and phosphatase inhibitors (ThermoFisher Scientific). 
Antibodies to the following epitopes were used: GluN2B N-terminus (MyBioSource, San Diego, CA, # 
MBS800075); phospho-Y1336 GluN2B (PhosphoSolutions, Aurora, CO, #p1516–1336); phospho-Y1472 GluN2B 
(Cell Signaling Technology, Boston, MA, #4208); pY416 Src (Cell Signaling Technology, #2101) and ß-actin 
(Santa Cruz Biotechnology, sc-47778). Appropriate secondary horseradish peroxidase-conjugated antibodies 
were used, and signal was visualized with enhanced chemiluminescence. Image J was used to measure the optical 
densities (OD, area × intensity) of the protein bands.
Immunoprecipitation (IP). Cultures were treated under the designated conditions for 5 minutes at 37 °C, 
then harvested in RIPA lysis buffer containing protease and phosphatase inhibitors. Samples were diluted with IP 
buffer (PBS containing 1% NP40 and protease and phosphatase inhibitors) and pre-cleared with Protein G beads 
(Invitrogen). IP was performed overnight at 4 °C with 4 μg mouse anti-GluN2B (MyBioSource, #MBS800075) 
or 4 μg normal mouse IgG (IgG2b, k isotype, BioLegend, #401202) as a negative control, then incubated with 
Protein G beads for 2 hr at 4 °C with rotation. After washing and centrifugation, the beads were boiled for 10 min 
in reducing sample buffer (Invitrogen). The samples were applied to SDS-PAGE electrophoresis and transferred 
to PVDF membranes. The membranes were incubated with rabbit GluN2B antibody (Cell Signaling Technology, 
#4212) or rabbit p85 antibody (Cell Signaling Technology, #4257), and then with goat anti-rabbit HRP-conjugated 
secondary antibodies. Immunoreactive proteins were visualized with enhanced chemiluminescence. The binding 
of p85 with GluN2B was expressed as the OD ratio of co-immunoprecipitated p85 with GluN2B.
Cell death. Cultures were incubated under the designated experimental conditions for 30 minutes at 37 °C, 
then transferred to fresh BSS and incubated for an additional 24 hours. All incubations were in 0% CO2 (room 
air). At 24 hours calcein green-AM (5 µM, Molecular probes) was added to identify living cells, and Hoechst 
33258 (1 µM, Molecular probes) to identify all cell nuclei. Analysis at the 24 hour time point was done to preclude 
the possibility of calcein leakage from viable cells through transiently opened pores. Photographs were taken of 
3 randomly determined fields of each culture well, and cell death was quantified by counting the number of cells 
labeled by Hoechst 33258 but not calcein green27. Cells were counted in 3 fields from a minimum of 4 wells per 
plate in each independent experiment.
Statistical analyses. In all cases, the ‘n’ values denote the number of independent experiments, each using 
neurons prepared from different mice. Each independent experiment contained triplicate culture wells or cover-
slips of each study condition, with measurements obtained from at least 200 neurons in each culture well or 10 
neurons on each coverslip. Data are expressed as means ± s.e.m. and assessed using one-way ANOVA followed by 
the Tukey-Kramer test where multiple groups are compared against one another, or Dunnett’s test where multiple 
groups are compared against a common control group.
Data Availability
Full length western blots corresponding to the cropped images presented in the figures are provided as Sup-
plementary Fig. 4. All datasets generated during this study are available from the corresponding author upon 
request.
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